FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/04/2023
Back to search
Official data from USPTO
MEGABULB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MEGABULB
ST13
US500000079333600Class
1, 5, 9
Filing
79333600
Registration
6993907
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/04/2023
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9
Filing date
09/22/2021
Registration date
03/07/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
03/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BLANE, SUZANNE
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LightBio Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid comprising natural and unnatural nucleotides for scientific and research purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for scientific and research purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for scientific and research purposes; all the aforesaid goods for use in nanotechnology applications in the nature of data storagedata retrieval and computing for scientific and research purposes; nucleic acids or nucleic acid analogues for labellingimaging and sensing applications for scientific and research purposes; nucleic acids or nucleic acid analogues as smart materials in the nature of smart therapeutic reagents and assays for scientific and research purposes; two-dimensional and three-dimensional nucleic acids or nucleic acid analogues for creating nanostructures and scaffolds for scientific and research purposes; chemical preparationsenzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in scientific research in the field of agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials in the nature of smart therapeutic reagents and assays; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds
Class 5
Vaccines; DNA based vaccines; DNA extractsnucleic acid sequences and chemical reagents for medical use; therapeutic DNAnucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials in the nature of smart therapeutic reagents and assays; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
Class 9
Electronic componentsnucleic acid analogues in the nature of electric wiressemi-conductorstransistorsrectifiersdiodeslight emitting diodes and energy storage systems in the nature of batteries and electrochemical devices configured for energy storagenamely electrolysersall comprising nucleic acids or nucleic acid analogues; parts and fittings for all the aforesaid technology and parts and fitting for all the aforesaid goodselectrical cablesdisplay screenstransmitters
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/12/2023
FIMP
FINAL DISPOSITION PROCESSED
06/11/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2022
PUBO
PUBLISHED FOR OPPOSITION
12/20/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/30/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2022
RFNT
REFUSAL PROCESSED BY IB
08/17/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/25/2022
RFRR
REFUSAL PROCESSED BY MPU
07/25/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2022
CNRT
NON-FINAL ACTION WRITTEN
06/27/2022
DOCK
ASSIGNED TO EXAMINER
06/24/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/17/2022
Continuous trademark protection
Get notified about every new filing that threatens MEGABULB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.